NEW YORK, Sept. 23 (GenomeWeb News) - Gene Logic said that it has lowered its revenue guidance for 2003 to a range of $72 million to $76 million, on a pro forma basis.

In late July, Gene Logic had said it was expecting its pro forma revenues for the year to be between $80 million to $84 million.

Gene Logic said that the pro forma results assume that the company's April 1 acquisition of TherImmune took place on January 1. Actual revenues for the year are expected to be in the range of $65 million to $69 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.